UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026122
Receipt number R000029909
Scientific Title A preliminary study of a predictor of treatment response to transcranial magnetic stiumulation in treatment-resistant depression
Date of disclosure of the study information 2017/02/14
Last modified on 2019/03/20 13:40:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A preliminary study of a predictor of treatment response to transcranial magnetic stiumulation in treatment-resistant depression

Acronym

Transcranial magnetic stiumulation in treatment-resistant depression

Scientific Title

A preliminary study of a predictor of treatment response to transcranial magnetic stiumulation in treatment-resistant depression

Scientific Title:Acronym

Transcranial magnetic stiumulation in treatment-resistant depression

Region

Japan


Condition

Condition

Treatment-resistant depression

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examination of efficacy of and exploration and identification of a predictor of treatment response to transcranial magnetic stimulation in treatment-resistant depression

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Assessment of depressive symptoms from the start point to eight weeks later

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Transcranial magnetic stimulation, dorsolateral prefrontal cortex, 4 weeks, 10 Hz, 100-120% MT (motor threshold), 4 sec, 3000 pulsed/day, 5 days/week

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Diagnosed as major depression by DSM-5
Larger than 14 in the score of HAMD 17
Less than three years in the period of the most recent depressive episode
Treatment-resistant in the present depressive episode

Key exclusion criteria

History of psychotic episode, bipolar disorder, obsessive-compulsive disorder, PTSD, or eating disorder
History of treatment of ECT, TMS, VNS, DBS, or tDCS
Pregnancy
History of convulsive disorder including epilepsy
History of neurological or organic brain disease
Diagnosed as drug or alcohol dependence
Magnetic substance in a body including pace-maker, cochlear implant, or intracranial clip
Having severe state of diseases of endocrine or metabolic system
Having severe level of suicide idea
Treated with the medicines which taper the convulsion thresholds

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Mamoru
Middle name
Last name Tochigi

Organization

Teikyo University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

173-8605

Address

2-11-1, Kaga, Itabashi

TEL

03-3964-1211

Email

mtoc-tky@umin.ac.jp


Public contact

Name of contact person

1st name Mamoru
Middle name
Last name Tochigi

Organization

Teikyo University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

173-8605

Address

2-11-1, Kaga, Itabashi

TEL

03-3964-1211

Homepage URL


Email

mtoc-tky@umin.ac.jp


Sponsor or person

Institute

Teikyo University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teikyo University Ethics Committee

Address

2-11-1, Kaga, Itabashi

Tel

03-3964-7256

Email

turb-office@teikyo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

15

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 07 Day

Date of IRB

2013 Year 07 Month 04 Day

Anticipated trial start date

2017 Year 02 Month 15 Day

Last follow-up date

2019 Year 02 Month 27 Day

Date of closure to data entry

2019 Year 02 Month 27 Day

Date trial data considered complete

2019 Year 02 Month 27 Day

Date analysis concluded

2019 Year 02 Month 27 Day


Other

Other related information



Management information

Registered date

2017 Year 02 Month 14 Day

Last modified on

2019 Year 03 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029909


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name